LON:TILSTiziana Life Sciences Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Tiziana Life Sciences PLC Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 109.90 +13.90 (+14.48 %) (As of 05/26/2020 06:44 AM ET) Add Compare Share Today's Range 96.25Now: GBX 109.90▼ 11250-Day Range 35MA: GBX 61.88▼ 9652-Week Range 23.50Now: GBX 109.90▼ 172.50Volume1.23 million shsAverage Volume4,999 shsMarket Capitalization£176.68 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsInsider TradesHeadlines Tiziana Life Sciences Plc, a clinical stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat diseases in oncology and immunology in the United Kingdom. The company's product pipeline includes Foralumab (TZLS-401), a human anti-CD3 monclonal antibody for the treatment of autoimmune and inflammatory diseases, such as non-alcoholic steatohepatitis, Crohn's disease, multiple sclerosis, type-1 diabetes, inflammatory bowel diseases, psoriasis, and rheumatoid arthritis; and Milciclib (TZLS-201), which is an orally bioavailable, small molecule inhibitor of cyclin-dependent kinases and Src family kinases for the treatment of hepatocellular carcinoma. It also develops TZLS-501, a human anti-interleukin-6 receptor monoclonal antibody that is in pre-clinical development. The company was founded in 2013 and is headquartered in London, the United Kingdom. Tiziana Life Sciences Plc is a subsidiary of Planwise Group Limited.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Tiziana Life Sciences. Previous Next 1.9 Community Rank Outperform VotesTiziana Life Sciences has received 120 “outperform” votes. (Add your “outperform” vote.)Underperform VotesTiziana Life Sciences has received 202 “underperform” votes. (Add your “underperform” vote.)Community SentimentTiziana Life Sciences has received 62.73% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Tiziana Life Sciences and other stocks. Vote “Outperform” if you believe TILS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe TILS will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldTiziana Life Sciences does not currently pay a dividend.Dividend GrowthTiziana Life Sciences does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Tiziana Life Sciences insiders have not sold or bought any company stock. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Tiziana Life Sciences are expected to grow in the coming year, from GBX (2.90) to GBX 0 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tiziana Life Sciences is -21.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tiziana Life Sciences is -21.96, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 1.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.51 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolLON:TILS Previous SymbolLON:ADI CUSIPN/A CIKN/A Webwww.tizianalifesciences.com Phone+44-20-74952379Debt Debt-to-Equity Ratio59.12 Current Ratio0.32 Quick Ratio0.31Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowGBX 0.46 per share Price / Cash Flow237.50 Book ValueGBX (2.40) per share Price / Book-45.79Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees10 Outstanding Shares160,767,008Market Cap£176.68 million Next Earnings DateN/A OptionableNot Optionable LSE:TILS Rates by TradingView Receive TILS News and Ratings via Email Sign-up to receive the latest news and ratings for TILS and its competitors with MarketBeat's FREE daily newsletter. Tiziana Life Sciences (LON:TILS) Frequently Asked Questions How has Tiziana Life Sciences' stock been impacted by COVID-19 (Coronavirus)? Tiziana Life Sciences' stock was trading at GBX 85 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, TILS stock has increased by 28.2% and is now trading at GBX 108.96. View which stocks have been most impacted by Coronavirus. How were Tiziana Life Sciences' earnings last quarter? Tiziana Life Sciences PLC (LON:TILS) announced its earnings results on Thursday, June, 7th. The biotechnology company reported ($6.40) earnings per share for the quarter, beating the consensus estimate of ($10.00) by $3.60. View Tiziana Life Sciences' earnings history. Has Tiziana Life Sciences been receiving favorable news coverage? News articles about TILS stock have trended very negative recently, according to InfoTrie. The research firm identifies negative and positive media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Tiziana Life Sciences earned a coverage optimism score of -3.0 on InfoTrie's scale. They also assigned media coverage about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news aboutTiziana Life Sciences. Who are some of Tiziana Life Sciences' key competitors? Some companies that are related to Tiziana Life Sciences include Bellus Health (BLU), CEL-SCI (CVM), Oxford BioMedica (OXB), Cel-Sci (CVM), SIGA Technologies (SIGA), Paradigm Biopharmaceuticals (PAR), Biotest (BIO), Neptune Wellness Solutions (NEPT), Silence Therapeutics (SLN), TELIX Pharmaceutical (TLX), Starpharma (SPL), ProMetic Life Sciences (PLI), IMV (IMV), Medicenna Therapeutics (MDNA) and Emblem (EMC). View all competitors. What other stocks do shareholders of Tiziana Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tiziana Life Sciences investors own include Synergy Pharmaceuticals (SGYP), ServiceNow (NOW), Broadcom (AVGO), Dropbox (DBX), Enterprise Products Partners (EPD), Franco Nevada (FNV), Micron Technology (MU), RingCentral (RNG), Tesla (TSLA) and Slack (WORK). Who are Tiziana Life Sciences' key executives? Tiziana Life Sciences' management team includes the following people: Mr. Gabriele Marco Antonio Cerrone M.B.A., MBA, Founder & Exec. Chairman (Age 47)Dr. Kunwar Shailubhai, CEO, Chief Scientific Officer & Exec. Director (Age 61)Dr. Andrea Brancale, Scientific FounderMr. Richard Clarkson Ph.D., Scientific FounderMr. Andrew Westwell Ph.D., Scientific Founder What is Tiziana Life Sciences' stock symbol? Tiziana Life Sciences trades on the London Stock Exchange (LON) under the ticker symbol "TILS." How do I buy shares of Tiziana Life Sciences? Shares of TILS and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Tiziana Life Sciences' stock price today? One share of TILS stock can currently be purchased for approximately GBX 108.96. How big of a company is Tiziana Life Sciences? Tiziana Life Sciences has a market capitalization of £175.17 million. Tiziana Life Sciences employs 10 workers across the globe. What is Tiziana Life Sciences' official website? The official website for Tiziana Life Sciences is www.tizianalifesciences.com. How can I contact Tiziana Life Sciences? Tiziana Life Sciences' mailing address is 3rd Fl, 11-12 St. James's Square, LONDON, SW1Y 4LB, United Kingdom. The biotechnology company can be reached via phone at +44-20-74952379. This page was last updated on 5/26/2020 by MarketBeat.com Staff
